Investment to help Cardiotrack expand its solutions to more health and life insurance providersCardiotrack, a leading provider of data-centric healthcare screening technology and services through health and life insurance providers, has received $2 million in Pre series-A funding from a slew of investors, led by seasoned angel investor Girish Narasimhan. Previously, the firm had received angel investment of $1.6 million from a cohort of UHNIs.Cardiotrack delivers the most comprehensive at-home pathology and radiology screening services, in 300+ locations through its strong pan-India network of diagnostic centres, technicians and phlebotomists equipped with its technology, to provide the best in the industry geographical coverage and turn-around time to its health and life insurance customers.A standout feature of Cardiotrack's unique screening technologies is the equivalent of a treadmill test, being conducted in the comfort of one's home along with video-based recorded medical examinations. Its state-of-the-art medical and IOT grade diagnostics devices, workflow automation and health data digitisation solutions empower health & life insurance providers to offer seamless onboarding experiences while enabling their customers to take control of their health. Cardiotrack provides insights into the health of consumers like never before. Currently, it serves nine health and life insurance companies, including most of the largest insurers in India.
